MA Khamashta

742 total citations
25 papers, 415 citations indexed

About

MA Khamashta is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, MA Khamashta has authored 25 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 9 papers in Immunology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in MA Khamashta's work include Systemic Lupus Erythematosus Research (21 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Systemic Sclerosis and Related Diseases (4 papers). MA Khamashta is often cited by papers focused on Systemic Lupus Erythematosus Research (21 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Systemic Sclerosis and Related Diseases (4 papers). MA Khamashta collaborates with scholars based in United Kingdom, Spain and United States. MA Khamashta's co-authors include Guillermo Ruiz‐Irastorza, Oier Ateka–Barrutia, Pier Luigi Meroni, David D’Cruz, Ricardo Cubedo Cervera, Y Shoenfeld, Pierre Youinou, Pilar Brito‐Zerón, Manuel Ramos‐Casals and Peter Izmirly and has published in prestigious journals such as Lupus, La Revue de Médecine Interne and Fetal and Maternal Medicine Review.

In The Last Decade

MA Khamashta

23 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MA Khamashta United Kingdom 11 250 127 119 73 58 25 415
Taneli Jouhikainen Finland 12 204 0.8× 74 0.6× 98 0.8× 41 0.6× 42 0.7× 20 408
E Scopelitis United States 13 282 1.1× 136 1.1× 83 0.7× 23 0.3× 88 1.5× 22 479
R.M. Silver United States 10 208 0.8× 74 0.6× 157 1.3× 103 1.4× 53 0.9× 27 496
M L Cuéllar United States 12 311 1.2× 124 1.0× 130 1.1× 101 1.4× 72 1.2× 19 618
Véronique Ramoni Italy 14 350 1.4× 212 1.7× 90 0.8× 167 2.3× 83 1.4× 36 599
Ann Rupel United States 6 337 1.3× 171 1.3× 46 0.4× 59 0.8× 26 0.4× 7 634
Antonia Calligaro Italy 16 494 2.0× 222 1.7× 223 1.9× 53 0.7× 44 0.8× 37 681
Ayhan Dinç Türkiye 16 274 1.1× 133 1.0× 107 0.9× 34 0.5× 46 0.8× 49 696
Cecilia Pisoni Argentina 9 435 1.7× 211 1.7× 53 0.4× 181 2.5× 61 1.1× 27 689
Kerry Gallagher United States 9 269 1.1× 79 0.6× 240 2.0× 34 0.5× 16 0.3× 13 496

Countries citing papers authored by MA Khamashta

Since Specialization
Citations

This map shows the geographic impact of MA Khamashta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MA Khamashta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MA Khamashta more than expected).

Fields of papers citing papers by MA Khamashta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MA Khamashta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MA Khamashta. The network helps show where MA Khamashta may publish in the future.

Co-authorship network of co-authors of MA Khamashta

This figure shows the co-authorship network connecting the top 25 collaborators of MA Khamashta. A scholar is included among the top collaborators of MA Khamashta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MA Khamashta. MA Khamashta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ateka–Barrutia, Oier & MA Khamashta. (2013). The challenge of pregnancy for patients with SLE. Lupus. 22(12). 1295–1308. 26 indexed citations
2.
Khamashta, MA, Ian N Bruce, Caroline Gordon, et al.. (2013). The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease. Lupus. 23(3). 273–283. 23 indexed citations
3.
Schreiber, Karen, et al.. (2011). OBSTETRIC ANTIPHOSPHOLIPID SYNDROME - A REVIEW. Fetal and Maternal Medicine Review. 22(4). 265–286. 1 indexed citations
4.
Cuadrado, MJ, M. Á. Aguirre, Nuria Barbarroja, MA Khamashta, & C. López-Pedrera. (2010). Proteomics in antiphospholipid syndrome: a review. Lupus. 19(4). 385–388. 5 indexed citations
5.
Ruiz‐Irastorza, Guillermo & MA Khamashta. (2008). Lupus and pregnancy: ten questions and some answers. Lupus. 17(5). 416–420. 51 indexed citations
6.
Davies, RJ, et al.. (2006). Antiphospholipid (Hughes) syndrome and atheroma. Lupus. 15(11_suppl). 55–58. 5 indexed citations
7.
Meroni, Pier Luigi, Nicoletta Del Papa, Elena Raschi, et al.. (1998). β2-Glycoprotein I as a ‘Cofactor’ for anti-phospholipid reactivity with endothelial cells. Lupus. 7(2_suppl). 44–47. 43 indexed citations
8.
Amengual, Olga, Tatsuya Atsumi, MA Khamashta, & Hughes Gr. (1996). Clinical significance of anti-beta 2-glycoprotein I antibodies.. PubMed. 147 Suppl 1. 15–7. 3 indexed citations
9.
Khamashta, MA, et al.. (1995). Clinical and Therapeutic Aspects of the Antiphospholipid Syndrome. Lupus. 4(1_suppl). S23–S25. 10 indexed citations
10.
Meroni, Pier Luigi, MA Khamashta, Pierre Youinou, & Y Shoenfeld. (1995). Mosaic of anti-endothelial antibodies. Lupus. 4(2). 95–99. 32 indexed citations
11.
Aydintug, AO., G. Tokgöz, D. D’Cruz, et al.. (1993). P 160 Antibodies to endothelial cells in patients with Behçet's disease. La Revue de Médecine Interne. 14. 133s–133s. 6 indexed citations
12.
Di̇reskeneli̇, Haner, Gökhan Keser, David D’Cruz, et al.. (1993). P 162 Anti-endothelial cell antibodies and endothelial cell dysfunction in Behçet's disease. La Revue de Médecine Interne. 14. 134s–134s. 2 indexed citations
13.
D’Cruz, David, et al.. (1992). Low dose methotrexate treatment in adult Still's disease.. PubMed. 19(3). 431–5. 48 indexed citations
14.
López-Dupla, Miguel, et al.. (1992). Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases.. PubMed. 87(12). 1771–6. 34 indexed citations
15.
Cervera, Ricard, MA Khamashta, José A. Font, et al.. (1992). [Anti-endothelial cell antibodies in systemic lupus erythematosus: association with vascular and renal lesions].. PubMed. 99(16). 605–8. 5 indexed citations
16.
Cervera, Ricard, MA Khamashta, Josep Font, et al.. (1992). SYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF DISEASES SUBSETS IN A COHORT OF 1000 PATIENTS (EURO-LUPUS PROJECT). 35(9).
17.
Ordï, Jaume, et al.. (1991). Platelet activation, endothelial cell dysfunction in the absence of anticardiolipin antibodies in systemic sclerosis.. PubMed. 18(12). 1833–6. 25 indexed citations
18.
Khamashta, MA, Asherson Ra, & Hughes Gr. (1990). Possible mechanisms of action of the antiphospholipid binding antibodies.. PubMed. 7 Suppl 3. S85–9. 7 indexed citations
19.
Khamashta, MA, et al.. (1989). Is there a role for phospholipases in the anti-cardiolipin syndrome?. PubMed. 6(4). 341–2. 4 indexed citations
20.
Valencia, Eulalia, et al.. (1987). [Determination of beta-2-microglobulin levels in patients with systemic lupus erythematosus: correlation with clinical and biological parameters].. PubMed. 181(6). 310–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026